Other studies have shown that P2X7R activation promotes neuroblastoma growth and proliferation by activating PI3K/GSK3 β/VEGF signaling, while the use of P2X7R antagonists (AZ10606120 or A740003) reduces neuroblastoma derived tumor growth38. This evidence concerns the gene VEGFA and neuroblastoma.